Table 3.

Postpartum health services and contraception uptake prior to and after Navigating New Motherhood

	Bivariable analyses				Multivariable analysis
	Prior to Navigating New Motherhood (N=256)	After Navigating New Motherhood (N=218)	p-value	OR (95% CI)	aOR (95% CI)*
Primary outcome
Postpartum visit attendance	180 (70.3)	192 (88.1)	<0.001	3.12 (1.91-5.09)	3.57 (2.11-6.04)
Secondary outcomes
WHO Tier 1 or 2 contraception uptake	167 (65.2)	161 (73.9)	0.04	1.51 (1.01-2.24)	1.56 (1.02-2.38)
LARC uptake	83 (33.6)	88 (40.4)	0.07	1.41 (0.97-2.06)	1.48 (1.00-2.20)
Completion of GTT (if eligible)	9 (30.0)	10 (47.6)	0.20	2.12 (0.67-6.76)	2.79 (0.80-9.70)
Received postpartum depression screen	160 (62.8)	177 (81.2)	<0.001	2.56 (1.68-3.92)	2.82 (1.79-4.43)
Breastfeeding at postpartum visit	97 (55.8)	102 (53.4)	0.65	0.91 (0.60-1.37)	0.94 (0.60-1.45)
Received influenza vaccine	152 (59.8)	161 (73.9)	0.001	1.90 (1.28-2.81)	2.10 (1.38-3.19)
Received HPV vaccination (if eligible)	27 (26.5)	29 (33.3)	0.01	2.29 (1.28-4.11)	2.33 (1.25-4.33)

Data displayed as N(%)

aOR, adjusted odds ratio; CI, confidence interval; WHO, World health organization; LARC, long-acting reversible contraception; GTT, glucose tolerance test; HPV, human papillomavirus

^*Controlling for transfer of care, asthma, and NICU admission